Adjuvant oxaliplatin with S-1 (SOX) versus S-1 for stage II-III gastric cancer (CAPITAL): A randomized, open-label, phase 3 trial. (linkinghub.elsevier.com)

Authors: Nie RC … Li YF Journal: Cell Med Published: 2026-08-14 DOI: https://doi.org/10.1016/j.medj.2026.101258